At Purdue, we’re focused on helping patients lead healthy and productive lives. For many years, Purdue has been committed to funding programs and providing resources to support the responsible use of prescription opioids.

“The ongoing opioid crisis lies at the intersection of two public health challenges – reducing the burden of suffering from pain and containing the rising toll of the harms that can result from the use of opioid medications.” – Consensus Study Report: Pain Management and the Opioid Epidemic, National Academies of Sciences, Engineering and Medicine, July 2017

Solving the crisis will take a broad set of stakeholders all doing their part to make a difference, Purdue included. We were the first company to introduce an opioid pain medication with abuse-deterrent properties and labeling claims, and we are investing in research to develop non-opioid pain medications. We are committed to being part of the solution by partnering with local law enforcement, state and local government agencies, and community groups across the country.

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.